Back to Search
OtherOpen Access

Metastatic function of METTL18 in breast cancer via actin methylation and Src

Author Affiliations
Sungkyunkwan University, The Ohio State University Wexner Medical Center, Samsung Medical Center, Cheongju University, ...
Published InbioRxiv (Cold Spring Harbor Laboratory)
Year2019
Citations3

Abstract

Abstract Recently, a SET domain containing 3 (SETD3) was identified as an actin histidine methyltransferase, functioning to control replication and pathogenesis in multiple mouse models for enterovirus infection as well as the regulation of smooth muscle contractility linked to primary dystocia. Here, in this study, we report another type of actin histidine methyltransferase, METTL18, that regulates the metastatic potential of breast cancer in human. Among methyltransferases, METTL18 was highly amplified in human breast cancer. In particular, poor prognosis was associated with high expression of METTL18 in HER2-negative breast cancer patients. This gene product was also found to be a critical component of metastatic responses. Loss of METTL18 expression significantly reduced metastatic responses of breast tumor cells both in vitro and…
View at Publisher

BORR does not host full-text PDFs. The button above takes you to the original publisher.